Your browser doesn't support javascript.
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series.
Truong, Thao T; Ryutov, Alex; Pandey, Utsav; Yee, Rebecca; Goldberg, Lior; Bhojwani, Deepa; Aguayo-Hiraldo, Paibel; Pinsky, Benjamin A; Pekosz, Andrew; Shen, Lishuang; Boyd, Scott D; Wirz, Oliver F; Röltgen, Katharina; Bootwalla, Moiz; Maglinte, Dennis T; Ostrow, Dejerianne; Ruble, David; Han, Jennifer H; Biegel, Jaclyn A; Li, Maggie; Huang, ChunHong; Sahoo, Malaya K; Pannaraj, Pia S; O'Gorman, Maurice; Judkins, Alexander R; Gai, Xiaowu; Dien Bard, Jennifer.
  • Truong TT; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, United States.
  • Ryutov A; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, United States.
  • Pandey U; Department of Pathology, Westchester Medical Center/New York Medical College, Valhalla, NY, United States.
  • Yee R; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, United States.
  • Goldberg L; Department of Pediatrics, Cancer and Blood Disease Institute, Division of Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, CA, United States; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • Bhojwani D; Department of Pediatrics, Cancer and Blood Disease Institute, Division of Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, CA, United States; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • Aguayo-Hiraldo P; Department of Pediatrics, Cancer and Blood Disease Institute, Division of Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, CA, United States; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States; Department of Pediatrics, Cancer and Blood Disor
  • Pinsky BA; Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.
  • Pekosz A; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Shen L; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, United States.
  • Boyd SD; Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States; Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, United States.
  • Wirz OF; Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.
  • Röltgen K; Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.
  • Bootwalla M; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, United States.
  • Maglinte DT; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, United States.
  • Ostrow D; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, United States.
  • Ruble D; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, United States.
  • Han JH; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, United States.
  • Biegel JA; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, United States; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • Li M; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Huang C; Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.
  • Sahoo MK; Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.
  • Pannaraj PS; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, United States.
  • O'Gorman M; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, United States; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • Judkins AR; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, United States; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • Gai X; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, United States; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • Dien Bard J; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, United States; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States. Electronic address: jdienbard@chla.usc.edu.
EBioMedicine ; 67: 103355, 2021 May.
Article in English | MEDLINE | ID: covidwho-1385438
ABSTRACT

BACKGROUND:

There is increasing concern that persistent infection of SARS-CoV-2 within immunocompromised hosts could serve as a reservoir for mutation accumulation and subsequent emergence of novel strains with the potential to evade immune responses.

METHODS:

We describe three patients with acute lymphoblastic leukemia who were persistently positive for SARS-CoV-2 by real-time polymerase chain reaction. Viral viability from longitudinally-collected specimens was assessed. Whole-genome sequencing and serological studies were performed to measure viral evolution and evidence of immune escape.

FINDINGS:

We found compelling evidence of ongoing replication and infectivity for up to 162 days from initial positive by subgenomic RNA, single-stranded RNA, and viral culture analysis. Our results reveal a broad spectrum of infectivity, host immune responses, and accumulation of mutations, some with the potential for immune escape.

INTERPRETATION:

Our results highlight the potential need to reassess infection control precautions in the management and care of immunocompromised patients. Routine surveillance of mutations and evaluation of their potential impact on viral transmission and immune escape should be considered.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Precursor Cell Lymphoblastic Leukemia-Lymphoma / Immune Evasion / SARS-CoV-2 / COVID-19 / Mutation Type of study: Experimental Studies / Observational study Topics: Variants Limits: Adult / Child, preschool / Female / Humans / Male / Young adult Language: English Journal: EBioMedicine Year: 2021 Document Type: Article Affiliation country: J.EBIOM.2021.103355

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Precursor Cell Lymphoblastic Leukemia-Lymphoma / Immune Evasion / SARS-CoV-2 / COVID-19 / Mutation Type of study: Experimental Studies / Observational study Topics: Variants Limits: Adult / Child, preschool / Female / Humans / Male / Young adult Language: English Journal: EBioMedicine Year: 2021 Document Type: Article Affiliation country: J.EBIOM.2021.103355